Medical University of Vienna: Dry Eye Syndromes trials

The registry lists 23 Dry Eye Syndromes studies with Medical University of Vienna as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 1Phase 3 2Phase 4 9No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Temporary Tear Duct Filling With Hyaluronic Acid Gel and Assessment of Dry Eye Disease (DED) After Bilateral Cataract SurgeryNot yet recruitingNCT07809022Phase 4
• Assessment of TFT by OCT in Healthy Subjects and Subjects With DESRecruitingNCT02585414
• Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface InflammationTerminatedNCT07245836Phase 4
• Detection of Acetylsalicylic Acid and Omega-3 Fatty Acids in Schirmers' Test Strips Using Mass SpectrometryCompletedNCT05775536Phase 2
• Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface InflammationCompletedNCT03907865Phase 4
• Effect of Lipid Based Eye Drops on Tear Film Lipid Layer ThicknessCompletedNCT03399292
• Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland DysfunctionCompletedNCT03162497Phase 4
• Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye SyndromeCompletedNCT03161080Not applicable
• Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02986750Phase 4
• Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02980913Not applicable
• Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585648Not applicable
• Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585453Phase 4
• Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye PatientsStatus unknownNCT02533154Phase 4
• Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy SubjectsCompletedNCT01970917Phase 4
• Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye SyndromeCompletedNCT01864330Phase 4
• Correlation of Different Signs for Assessment of Dry Eye SyndromeCompletedNCT01753687Not applicable
• Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye DiseaseWithdrawnNCT01753596Phase 3
• Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact LensesCompletedNCT01747616Phase 1
• Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy SubjectsCompletedNCT01744457Not applicable
• The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
• Treatment of Dry Eye With SupplementsWithdrawnNCT01364311Not applicable
• Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01278784Phase 1
• Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01015209Phase 1